| Financial Year |
March 31 2023 |
| Monetary Funds |
5,414,981,027.08 |
| Held-for-trading Financial Assets |
46,660,427.40 |
| Notes Receivable |
234,299,731.65 |
| Accounts Receivable |
916,657,758.56 |
| Advances to Suppliers |
14,015,709.02 |
| Other Receivables |
247,505,934.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
680,433,646.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
76,469,506.38 |
| Total Current Assets |
7,769,217,663.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
715,691,064.19 |
| Investment Properties |
-- |
| Fixed Assetes |
4,381,785,139.31 |
| Under-construction Projects |
1,568,434,363.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
283,754,543.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
151,762,096.45 |
| Deferred Income Tax Assets |
66,649,207.20 |
| Other Non-Current Assets |
92,489,771.03 |
| Sub-Total of Non-Current Assets |
8,094,661,056.88 |
| Total Assets |
15,863,878,720.52 |
| Short-Term Loans |
104,198,725.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
381,910,219.80 |
| Accounts Payable |
1,331,260,085.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,725,536.56 |
| Taxes Payable |
7,653,598.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
124,073,250.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
161,786,646.23 |
| Other Current Liabilities |
225,284,547.88 |
| Sub-Total of Current Liabilities |
2,481,389,646.10 |
| Long-term Loans |
920,460,738.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,454,548.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
27,123,120.23 |
| Deferred Income Tax Liabilities |
56,136,522.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,281,423,136.22 |
| Total Liabilities |
3,762,812,782.32 |
| Paid-In Capital(Or Share Stock) |
1,157,013,211.00 |
| Capital Surplus |
7,150,673,688.61 |
| Surplus Reserve |
610,538,422.29 |
| LESS:Treasury Stock |
104,862,156.47 |
| Undistributed Profits |
2,886,663,441.59 |
| Minority Stockholder's Interest |
145,377,596.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,955,688,341.61 |
| Owner's Equity（Stockholder's Equity） |
12,101,065,938.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,863,878,720.52 |
